ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity (Praire)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00957866
Recruitment Status : Completed
First Posted : August 13, 2009
Last Update Posted : May 16, 2014
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
University of Manitoba

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : November 2012